Lixte Biotechnology Holdings, Inc. Common Stock

Go to Lixte Biotechnology Holdings, Inc. Common Stock Website

$4.46

-0.40 (-8.23%)
Live
Previous Close

$4.38

Day Range

$4.24 - $4.8

Previous Day Range

$4.6428 - $5.14

Market Cap

$14.7 million USD

Day Vol.

102724

Previous Day Vol.

193969

Currency

USD

Primary Exchange

Nasdaq

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

LIXTE Biotechnology Holdings, Inc. has filed a request to withdraw its Registration Statement on Form S-1, as the company no longer intends to pursue a public offering at this time.

Related tickers: LIXT, LIXTW.

Read Full Article

Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system

Related tickers: LIXT, LIXTW.

Read Full Article
Trending Tickers

Please sign in to view